But here is the gap that critics point to: BPC-157 has been tested in roughly 30 humans, compared to the hundreds of thousands of patients evaluated in GLP-1 drug trials
When to Adjust Dosing Increase dose if: After 4-6 weeks at current dose, no measurable body composition changes occur, youre tolerating current dose without side effects, youre below the upper clinical range (1 mg daily), and your physician approves escalation based on comprehensive assessment
These findings indicated that early intervention with NHPN-1010 confers treatment-specific effectiveness in promoting cochlear synaptogenesis
The catch is that production slows with age, and it's also affected by poor sleep, alcohol, pollution and chronic stress all fairly unavoidable if you live and work in a major Indian city
The practical answer is that these products may not compete in exactly the same way
I think of this as a kind of defensive monotropic mode